Khrom Capital Management, which together with its investment funds and affiliates, owns 5.5% of Acadia Healthcare (ACHC) Company, and is one of the company’s largest shareholders, sent a letter to the company’s Board of Directors reiterating its belief that the company should pursue a formal review of strategic alternatives, including a sale, in order to maximize value for its shareholders.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Unveils 2026 Guidance at Jefferies Conference
- Acadia Healthcare price target lowered to $29 from $35 at Deutsche Bank
- Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
- Acadia Healthcare says focused on enhancing value for all shareholders
- Engine Capital builds 3% stake in Acadia, urges board refresh, FT reports